Search results for "Coronavirus"
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
New research looks at COVID-19 quarantine length in asymptomatic contacts, convalescent plasma for mild disease, related health issues
Seven-day quarantine may be sufficient for contacts without symptoms, older adults with mild disease may benefit from convalescent plasma, and cardiovascular deaths increased during the early stage of the pandemic.
https://immattersacp.org/weekly/archives/2021/01/12/3.htm
12 Jan 2021
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
Q&A with ACP's President on COVID-19 vaccines
George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
Boosters, convalescent plasma, long-term effects, and other COVID-19 news
Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021
New ACP resources on primary care reopening and recovery available
Resuming primary care is a key priority for supporting the U.S. health care system's capacity to manage and recover from the COVID-19 pandemic.
https://immattersacp.org/weekly/archives/2020/06/02/2.htm
2 Jun 2020
Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021
Third shot for immunocompromised patients, ACP and others urge vaccine in pregnancy, more COVID-19 news
The FDA and multiple new studies supported a third vaccine dose for organ transplant patients, an ACP statement and an observational trial highlighted benefits of vaccination during pregnancy, and a randomized trial found benefit from budesonide in high-risk outpatients with COVID-19.
https://immattersacp.org/weekly/archives/2021/08/17/1.htm
17 Aug 2021
Explore new content, enhanced search functionality on ACP's Online Learning Center
The Online Learning Center is a centralized gateway to more than 350 online learning activities that are CME and MOC eligible, many of which are free to ACP members.
https://immattersacp.org/weekly/archives/2020/02/25/6.htm
25 Feb 2020